Eagle's Eye View: Your Weekly CV Update From ACC.org
Detalls del Canal
Eagle's Eye View: Your Weekly CV Update From ACC.org
The weekly cardiovascular update from Kim Eagle, MD, MACC for ACC.org covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.
Episodis Recents
115 episodis
The State of CV Health in the US; Semaglutide and Reduced Hospital Admissions; D-Dimer and Its Use in Ruling Out DVT
In this week's View, Dr. Eagle comments on the recently published JACC Cardiovascular (CV) Statistics report which evaluates the management of CV risk...
Reducing Fat & Reducing Mortality & Stroke; Tirzepatide s. Dulaglutide; Finerenone and Hypotension; Low Operator Volume and Worse Outcomes
In this week's View, Dr. Eagle evaluates the impacts that reducing saturated fat have on mortality, nonfatal myocardial infarction (NFMI), and stroke...
Eagle's Eye View: Top 2025 ACC Content
In this episode, Dr. Eagle looks back at 2025 and explores some of the significant developments that show how the College is responding to changes in...
Weight Reversal Post Tirzepatide Withdrawal
In this week's View, Dr. Eagle looks at the DANISH trial extended follow-up, evaluating which patients benefit most from primary prevention implantabl...
The PREVENT Equations & Cardiovascular Risk, the CREST-2 Trials on Carotid Disease , Physician Burnout, Food Labeling & CV Health
In this week's View, Dr. Eagle looks at the use of PREVENT equations to assess cardiovascular (CV) disease risk and the CREST-2 randomized trials that...
Improving The Culture and Climate Surrounding Cardiology
In this week's View, Dr. Eagle looks at the potential for electrophysiology (EP) ablation in ambulatory care. He then explores several new studies tha...
Gastrointestinal Bleeding After LAAO, Lifestyle Modification & Metabolic Syndrome, Beta-Blockers & the Treatment of Preserved LVEF
In this week's View, Dr. Eagle looks at gastrointestinal bleeding (GIB) after left atrial appendage occlusion (LAAO). He then explores lifestyle modi...
Eagle's Eye View: Highlights from the 2025 AHA Scientific Sessions
In this week's View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions. The OCEAN...
Highlights From 2025 TCT Conference
In this week's View, Dr. Eagle highlights several trials recently presented at the TCT Conference in San Francisco. The SELUTION DeNovo trial found th...
Aspirin, Anticoagulants, & Chronic Coronary Disease; Perioperative Blood Pressure Management; High-Dose Flu Vaccines & Hospitalizations
In this week's View, Dr. Eagle looks at a study comparing the use of aspirin and oral anticoagulants versus anticoagulants alone in the treatment of c...
Heart Disease Mortality in California; Pregnant Women and Cardiometabolic Comorbidities; CABG and New-Onset AFib
In this week's View, Dr. Eagle looks at the social drivers behind the rise in heart disease mortality in California. He then explores the prevalence o...
Evidence and Innovations Targeting Inflammation Post-AMI
In this week's View, Dr. Eagle looks at the potential value of sodium-glucose cotransporter 2 (SGLT2) agents after transcatheter aortic valve implanta...
A Look at ACC’s Scientific Statement on Inflammation and CVD
In this week's View, Dr. Eagle looks at an ACC Scientific Statement highlighting inflammation and its role in cardiovascular disease (CVD). He then ex...
Oral Semaglutide for Weight Loss; Anticoagulants for PAH; The ECDP on TR Evaluation and Management
In this week's View, Dr. Eagle looks at the value of oral semaglutide for weight loss. He then explores whether anticoagulants improve survival in pat...
Nonatherothrombotic Myocardial Infarction and SCAD in Younger Patients; the Benefit of Intensive Blood Pressure Control; Clopidogrel vs. Aspirin for Prevention of CV Events
In this week's View, Dr. Eagle looks at the net benefit of intensive blood pressure control between fewer cardiovascular and more adverse events. He t...
Aspirin in PCI; Mavacamten in Nonobstructive Cardiomyopathy; Olezarsen and the Treatment of Hypertriglyceridemia
Dr. Eagle continues in this week's View to analyze some of the key clinical content presented at the ESC Congress recently held in Spain. Dr. Eagle ex...
Aficamten vs. Metoprolol for HCM; Beta Blocks and Myocardial Infarction (MI); Reconditioned Pacemakers for Improving Global CV Health
In this week's View, Dr. Eagle looks at major trials presented at the recent ESC Congress in Spain. First, he discusses the MAPLE-HCM trial that inves...
Self-Service Blood Pressure Kiosks; the FLAVOUR Trial & Intermediate Coronary Stenosis; CPAP & Cardiovascular Outcomes
In this week's View, Dr. Eagle evaluates the potential value of self-service blood pressure (BP) kiosks and their potential to improve hypertensive he...
New ACC/AHA Blood Pressure Guidelines; Right Angle Branch Blocks & Pacemakers; Gender-Affirming Care & Cardiac Repolarization
In this week's View, Dr. Eagle looks at the new ACC/AHA guideline for prevention, detection, evaluation and management of high blood pressure (BP). He...
Compression Socks & Vasovagal Syncope; Management of Pericarditis; Early Cardiac Rehab for ADHF.
In this week's View, Dr. Eagle looks at whether compression stockings reduce vasovagal syncope recurrence. He then discusses new concise clinical guid...
BMI, Adiposity & Tirzepitide and HFpFF; BAV-0 and Aortic Stenosis; Infective Endocarditis and Mitral Valve Replacement
In this week's View, Dr. Eagle looks at the SUMMIT trial and considers how body mass index (BMI) and central adiposity affect tirzepatide outcomes for...
BMI, Adiposity & Tirzepitide and HFpFF; BAV-0 and Aortic Stenosis; Infective Endocarditis and Mitral Valve Replacement
In this week's View, Dr. Eagle looks at the SUMMIT trial and considers how body mass index (BMI) and central adiposity affect tirzepatide outcomes for...
The PREVENT Model & Risk Prediction; Carbohydrate Quality & Improved LV Structure; Radial Access for PCI & Lower Complication Rates
In this week's View, Dr. Eagle looks at the PREVENT model and its ability to predict ten-year atherosclerotic cardiovascular disease risk in diverse p...
AV after TTVR; Deep Learning in Automating Cardiac IMG; Survival Benefits Post-2018 Heart Transplantation Policy Change
In this week's View, Dr. Eagle looks at predictors of high-grade atrioventricular block (AV) after transcatheter tricuspid valve replacement (TTVR). H...
Ischemic Preconditioning & Noncardiac Surgery; The Microaxial Flow Pump in STEMI-CS; DOACs After Strokes
In this week's View, Dr. Eagle looks at whether ischemic preconditioning provides benefit in noncardiac surgery. He then discusses the benefits of th...
Frailty Status and Mortality Risk in PCI; Delays in Treatment in STEMI; Arterial Events with Genetic-based Vascular Disease
In this week's View, Dr. Eagle looks at frailty status and increased risk of mortality in patients who undergo percutaneous coronary intervention (PCI...
LAAO and the Watchman FLX; HF Care in Private Equity Hospitals; Long-term Outcomes in TR and Mitral Valve-in-Valve Replacement
In this week's View, Dr. Eagle looks at the lower risk of major adverse events in patients with left atrial appendage occlusion (LAAO) using the Watch...
Marijuana Use & Endothelial Function; CV & Bleeding With Aspirin v. Clopidogrel; Mental Health for Survivors of SCA and ICD Shock
In this week's View, Dr. Eagle looks at chronic marijuana smoking and THC-edible use and its impairment of endothelial function. He then discusses the...
Carvedilol To Treat HFimpEF; Modifiable Lifestyle Factors & Cardiac Conduction Disease; Amiloride vs. Spironolactone for Resistant Hypertension
In this week's View, Dr. Eagle looks at the CATHEDRAL-HF Trial and its study of carvedilol's effectiveness as a monotherapy in heart failure with imp...
Colchicine vs. Placebo in Reducing CV Events; DOACs vs. Warfarin After TAVR; CSP vs. BiVP and Echo Response
In this week's View, Dr. Eagle looks colchicine versus placebo in reducing major adverse cardiovascular (CV) events including CV death or myocardial i...
ORBITA-2 & PCI; Blood Pressure Control & Increasing Medication Prescriptions; Rapid Initiation & Titration in GRMT for Patients with HFrEF
In this week's View, Dr. Eagle looks at the results of the ORBITA-2 Trial and its use in stress echocardiography before PCI. He then discusses the pro...
Lp(a) and CV Risk; CRP Levels and High-Risk Vulnerable Plaque post-NSTEMI; Pulsed Field Ablation vs. Cryoablation for Paroxysmal AFib
In this week's View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactiv...
Weight Management in Pregnancy and CVD Risk; Impact of Statins Plus Ezetimibe Post-MI; PARTNER-3 Study 5-year Results
In this week's View, Dr. Eagle examines weight management in pregnancy related to cardiovascular disease (CVD) risk. He then considers how the additio...
Outcomes of Pre-ablation Transesophageal Echocardiograms; TAVI vs. SAVR in Women With Severe AS; Effects in the Use of Oral Anti-coagulants (OACs)
In this week's View, Dr. Eagle examines the effects on patients who have undergone pre-ablation transesophageal echocardiogram (TEE) versus those who...
Key Takeaways from ACC.25 Major Trials and Presentations
In this week's View, Dr. Eagle looks at the major trials and presentations from the recently concluded ACC.25 in Chicago. This episode includes covera...
Cardiogenic Shock Guidance; Mortality after Mitral Repair & TAVR; Direct-to-Physician Marketing Affects GDMT
In this week's View, Dr. Eagle looks at the latest clinical guidance on the management of cardiogenic shock. He then discusses trends in mortality aft...
Smoking & CVD Risk; Sleep, Diabetes, & Women with Gestational Diabetes; Post-TAVR Imaging
In this week's View, Dr. Eagle examines the dose-response relationship between smoking and subclinical cardiovascular disease markers. He then discuss...
Short-term DAPT, PCI & High Bleeding Risk; Dapagliflozin & Heart Failure; Non-Pharmacologic Treatment of HF
In this week's View, Dr. Eagle looks at a sex-based analysis of short-term dual antiplatelet therapy (DAPT) in patients receiving percutaneous coronar...
Identifying Myocardial Infarction after PCI; Myocardial Fibrosis & Severe Aortic Valve Stenosis; Anticoagulation & Cancer Diagnoses
In this week's View, Dr. Eagle looks at the optimal threshold for identifying a myocardial infarction (MI) after PCI. He then discusses myocardial fib...
SGLT2 Inhibitors & Aortic Valve Stenosis; Early vs. Later Ablation for Afib; Sports Participation by Athletes with Cardiac Abnormalities
In this week's View, Dr. Eagle looks at the potential exposure-dependent protective effect of SGLT2 inhibitors on aortic valve stenosis progression. H...